Association between Mycoplasma genitalium and clinical findings, according to whether vaginal discharge had been noted. The baseline category consists of FSW who were negative for NG, CT, MG, and TV
| No vaginal discharge | Vaginal discharge present | p Value, test for interaction | |||||
|---|---|---|---|---|---|---|---|
| NG− CT− MG− TV− | MG+ | OR (95% CI) | NG− CT− MG− TV− | MG+ | OR (95% CI) | ||
| *p<0.05; **p<0.001. | |||||||
| †Presence of a yellow cervical exudate (“swab test”). | |||||||
| Cervical discharge | |||||||
| Yes | 24 (7.1%) | 33 (20.1%) | 3.3 | 8 (11.8%) | 5 (9.4%) | 0.8 | 0.03 |
| No | 316 | 131 | (1.8 to 6.1)** | 60 | 48 | (0.2 to 2.9) | |
| Pus on cervical swab† | |||||||
| Yes | 20 (6.0%) | 29 (18.0%) | 3.5 | 8 (14.5%) | 5 (11.1%) | 0.7 | |
| No | 316 | 132 | (1.8 to 6.7)** | 47 | 40 | (0.2 to 2.8) | 0.02 |
| Bleeding after sampling | |||||||
| Yes | 8 (2.4%) | 18 (11.0%) | 5.2 | 5 (7.2%) | 8 (15.1%) | 2.3 | 0.27 |
| No | 332 | 145 | (2.0 to 13.4)** | 64 | 45 | (0.6 to 8.8) | |
| Inflammatory cervix | |||||||
| Yes | 23 (6.8%) | 31 (19.0%) | 3.2 | 13 (19.1%) | 9 (17.3%) | 0.9 | 0.02 |
| No | 317 | 132 | (1.7 to 6.0)** | 55 | 43 | (0.3 to 2.5) | |
| Cervical motion tenderness | |||||||
| Yes | 27 (7.9%) | 27 (16.5%) | 2.3 | 16 (23.2%) | 12 (22.6%) | 1.0 | 0.10 |
| No | 313 | 137 | (1.2 to 4.2)* | 53 | 41 | (0.4 to 2.5) | |